tiprankstipranks
Voyager Therapeutics (VYGR)
NASDAQ:VYGR
US Market
VYGR
Voyager Therapeutics
RESEARCH TOOLSreports
Want to see VYGR full AI Analyst Report?

Voyager Therapeutics (VYGR) Income Statement

1,343 Followers

Voyager Therapeutics Income Statement

Last quarter (Q4 2025), Voyager Therapeutics's total revenue was $15.34M, an increase of 144.28% from the same quarter last year. In Q4, Voyager Therapeutics's net income was $-27.43M. See Voyager Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 40.37M$ 80.00M$ 250.01M$ 40.91M$ 37.41M
Gross Profit
$ 40.37M$ 80.00M$ 157.84M$ -14.86M$ -36.37M
Operating Expenses
$ 172.22M$ 163.29M$ 35.82M$ 35.98M$ 37.25M
Depreciation and Amortization
$ 4.06M$ 4.73M$ 4.44M$ 6.19M$ 5.17M
EBITDA
$ -127.78M$ -78.56M$ 126.45M$ -39.65M$ -68.45M
Operating Income
$ -131.84M$ -83.29M$ 122.01M$ -50.84M$ -73.62M
Other Income/Expenses
$ 12.27M$ 18.95M$ 11.72M$ 4.45M$ 2.42M
Pretax Income
$ -119.58M$ -64.34M$ 133.74M$ -46.39M$ -71.20M
Net Income
$ -119.72M$ -65.00M$ 132.33M$ -46.41M$ -71.20M
Per Share Metrics
Basic EPS
$ -2.04$ -1.13$ 3.08$ -1.21$ -1.75
Diluted EPS
$ -2.04$ -1.13$ 2.97$ -1.21$ -1.75
Weighted Average Shares Outstanding
 58.69M 57.67M 43.02M 38.36M 37.67M
Weighted Average Shares Outstanding (Diluted)
 58.69M 57.67M 44.57M 38.36M 37.67M
Currency in USD

Voyager Therapeutics Earnings and Revenue History